TY - JOUR
T1 - Examples of doping control analysis by liquid chromatography-tandem mass spectrometry
T2 - ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins
AU - Thevis, Mario
AU - Schänzer, Wilhelm
PY - 2005/1/1
Y1 - 2005/1/1
N2 - The application of modern and powerful analytical instruments consisting of liquid chromatographs (LCs), sophisticated atmospheric pressure ion sources, and sensitive mass analyzers has improved quality as well as speed of doping control analyses markedly during the last 5 years. Numerous compounds such as beta-receptor blocking agents or diuretics require derivatization prior to gas chromatographic (GC) and mass spectrometric (MS) measurement, which is the reason for extended sample preparation periods. In addition, several substances demonstrate poor GC-MS properties even after chemical modification, and peptide hormones such as cross-linked hemoglobins cannot be analyzed at all by means of GC-MS. With the availability of electrospray ionization and robust tandem MSs (e.g., triple-stage quadrupole or ion trap instruments) many new or complementary screening and confirmation assays have been developed, providing detailed qualitative and quantitative information on prohibited drugs. With selected categories of compounds (ephedrines, beta-blockers, b2-agonists, diuretics, and bovine hemoglobin-based oxygen therapeutics) that are banned according to the rules of the World Anti-Doping Agency and International Olympic Committee, the advantages of LC-MS-MS procedures over conventional GC-MS assays are demonstrated, such as enhanced separation of analytes, shorter sample pretreatment, and identification of substances that are not identified by GC-MS.
AB - The application of modern and powerful analytical instruments consisting of liquid chromatographs (LCs), sophisticated atmospheric pressure ion sources, and sensitive mass analyzers has improved quality as well as speed of doping control analyses markedly during the last 5 years. Numerous compounds such as beta-receptor blocking agents or diuretics require derivatization prior to gas chromatographic (GC) and mass spectrometric (MS) measurement, which is the reason for extended sample preparation periods. In addition, several substances demonstrate poor GC-MS properties even after chemical modification, and peptide hormones such as cross-linked hemoglobins cannot be analyzed at all by means of GC-MS. With the availability of electrospray ionization and robust tandem MSs (e.g., triple-stage quadrupole or ion trap instruments) many new or complementary screening and confirmation assays have been developed, providing detailed qualitative and quantitative information on prohibited drugs. With selected categories of compounds (ephedrines, beta-blockers, b2-agonists, diuretics, and bovine hemoglobin-based oxygen therapeutics) that are banned according to the rules of the World Anti-Doping Agency and International Olympic Committee, the advantages of LC-MS-MS procedures over conventional GC-MS assays are demonstrated, such as enhanced separation of analytes, shorter sample pretreatment, and identification of substances that are not identified by GC-MS.
KW - Adrenergic beta-Antagonists
KW - Animals
KW - Blood Substitutes
KW - Cattle
KW - Chromatography, Liquid
KW - Cross-Linking Reagents
KW - Diuretics
KW - Doping in Sports
KW - Ephedrine
KW - Gas Chromatography-Mass Spectrometry
KW - Humans
KW - Mass Spectrometry
KW - Sympathomimetics
UR - https://www.scopus.com/pages/publications/12844262768
M3 - Journal articles
C2 - 15808003
SN - 0021-9665
VL - 43
SP - 22
EP - 31
JO - Journal of chromatographic science
JF - Journal of chromatographic science
IS - 1
ER -